Dr. Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences, and Pathology & Molecular Medicine at Queen's University. He is an attending physician in Infectious Diseases and Internal Medicine and Medical Director of Infection Prevention & Control at Kingston General Hospital and the Hotel Dieu Hospital. He served as President of the Association of Medical Microbiology and Infectious Disease (AMMI) Canada from 2008-10. He is a founding member of the Ontario Anti-infective Review Panel and immediate past Chair of the Committee to Evaluate Drugs, the Ontario Ministry of Health and Long-Term Care expert advisory committee on optimal drug utilization for the province of Ontario. He is also a co-investigator with the Ontario Drug Policy Research Network and Chair of the Working Group on Drugs for Rare Diseases for the Ontario MOHLTC. His research interests include clinical guideline development, antimicrobial pharmacology, the microbiology of well water and aquifers, and knowledge translation and health technology assessment for optimal drug utilization.
Dr. Gerald Evans is a Professor in the Departments of Medicine, Microbiology & Immunology, and Pathology & Molecular Medicine at Queen's University and an attending physician in Infectious Diseases and Internal Medicine at Kingston General Hospital and the Hotel Dieu Hospital in Kingston, Ontario. Dr. Evans graduated cum laude from the University of Ottawa School of Medicine in 1982 and completed his training in Internal Medicine with residencies at the University of Toronto and University of Ottawa from 1982-87. He completed his fellowship in Infectious Diseases at the University of Calgary in 1990. Dr. Evans was the first Chair of the Division of Infectious Diseases at Queen’s. He has also served as the Program Director for the Internal Medicine Postgraduate Training Program of the Department of Medicine at Queens from 1997-2001 and is a current member of the RCPSC Examination Board in Internal Medicine. He has also served as a member of the RCPSC Examination Board in Infectious Diseases from 1995-2005.
Dr. Evans is a former two-term councillor with CIDS and AMMI Canada and currently the President of AMMI Canada. He is a member of the Ontario Anti-infective Review Panel, and former Chair of the Guidelines Committee of the Association of Medical Microbiology and Infectious Disease (AMMI) Canada. He is the current Chair of the Committee to Evaluate Drugs of the Ontario Ministry of Health and Long-Term Care, an expert advisory committee on optimal drug utilization for the province of Ontario.
His clinical and research interests include guideline development, antimicrobial pharmacology, sexually transmitted infections; particularly genital herpes, respiratory tract infections, antifungal therapy and infections caused by Staphylococcus aureus.
- Clinical Trials of Investigational Antimicrobials
- Antimicrobial Pharmacology
- Outpatient Parenteral Antibiotic Therapy (OPAT)
- Epidemiology of Human Infectious Diseases
- Community-Acquired Pneumonia (CAP)
- Human Herpesvirus Infections
Details of Research Interests:
As an Infectious Disease physician, I am actively involved in clinical trials of new antimicrobials for use in the treatment of human infectious diseases. I have a particular interest in the antimicrobial therapy of community-acquired pneumonia and human herpesvirus infections. In collaboration with other clinical colleagues in Infectious Diseases here at Queen's we are pursuing studies in the epidemiology of tuberculosis, infective endocarditis, human staphylococcal infections including bone and joint infections and CAPD peritonitis, and risk factors for CAP. We are participating in an international project examining the management of patients on ambulatory parenteral antibiotic therapy, an emerging strategy for treating patients outside of the hospital setting. In collaboration with colleagues in pharmacy we are examining the importance of antimicrobial pharmacokinetics and other parameters on the efficiency of delivering antibiotic therapy outside the hospital setting.
A Majury, J Ash, B Toye, G Evans, T Mazzulli, AL Winter, G Gamble: Laboratory diagnosis of human infection with avian influenza CMAJ 2006; 175:1371-2
G Ma, A Tisseverasinghe, P Toren, D Tam, S McKenna, GA Evans The Safety of First Dose Home Intravenous Antibiotic Therapy Can J Hosp Pharm 2007; 60: 106-13
M Mamdani, D McNeely, GA Evans, J Hux, P Oh, N Forde, J Conly: A Population-Based Study Of The Immediate Impact Of A Fluoroquinolone Restriction Policy On Antibiotic Utilization And Hospitalization Outcomes Among An Elderly Population Am J Med 2007;120:893-900'
C Rotstein C, GA Evans, A Born, R Grossman, RB Light, S Magder, B McTaggart: Clinical Practice Guidelines for Hospital-Acquired (HAP) Pneumonia and Ventilator-Associated Pneumonia (VAP) in Adults Can J Infect Dis Med Micro 2008;19:19-5
AP Johnson, NJ Sikich, G Evans, W Evans, M Giacomini, M Glendining, M Krahn, L Levin, P Oh, C Perera,: Health Technology Assessment - A Comprehensive Framework for Evidence-Based Recommendations in Ontario International Journal of Technology Assessment in Health Care 2009; 25(2):141-150N.J.
WW Pilla, PA Rosser, RA Pennie and the Anti- infective Review Panel. Anti-infective Guidelines for Community-acquired Infections, 3rd Edition Toronto: MUMS Guideline Clearinghouse. 2001
GA Evans: "The Oxazolidinones" Curr Infect Dis Rep 2002; 4:17-27
P Brill-Edwards, L Couture, G Evans, P Hamilton, I Hramiak, D Megran, ML Schmuck, G Cole, N Mikhael, G Norman: Predicting performance on the Royal College of Physicians and Surgeons of Canada internal medicine written examination. CMAJ 2001; 165:1305-7
S McKenna, GA Evans, and the CIDS Antimicrobial Agents Committee: "Macrolides: A CIDS Position Paper" Can J Infect Dis 2001; 12:218-231
The Kingston Hospitals Antimicrobial Handbook, Second Edition 1998-99 Editors: GA Evans, S. McKenna 1999, Kingston, ON
AP Johnson, NJ Sikich, G Evans, W Evans, M Giacomini, M Glendining, M Krahn. L Levin, P Oh, C Perera: “Health Technology Assessment - A Comprehensive Framework For Evidence-Based Recommendations” 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) May 2009 Orlando, FL
I Lowy, B LEav, BM Blair, R Baxter, D Gerding, G Nichol, R Kohberger, M Leney, SE Sloan, DC Molrine, DM Ambrosino and the GS-CDA1 and MDX-1388 Study Group “Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. Difficile Recurrence” 40th Annual Digestive Diseases Week May/June 2009, Chicago, IL
S McKenna, G Evans, T Stevenson, C Fuller, J Ekborn, W Wobeser: “Proteinuria in Tenofovir-treated Patients with HIV Infection” 26th International Congress of Chemotherapy and Infection Conjoint AMMI Canada-CACMID Annual Conference June 2009, Toronto, ON
K Minnings, G Evans, T Day, A Majury: “Pandemic Influenza: A Laboratory Testing Model” 26th International Congress of Chemotherapy and Infection Conjoint AMMI Canada-CACMID Annual Conference June 2009, Toronto, ON
J Yeung, G Evans, V Kratky: "Orbital 'Cellulitis' with Vascular Occlusion as First Presentation of SLE" Canadian Ophthalmological Society 72nd Annual Meeting, June 2009 Toronto, ON